Eris Lifesciences (ERIS) Share Price hits fresh 52-week low, trades at Rs 1,158.95

Eris Lifesciences Share Price is trading at Rs 1,158.95 after falling 2.42% from the previous close of Rs 1,187.65. The stock touched a fresh 52-week low of Rs 1,158.95 and is being tracked with a market capitalisation of Rs 16,468.27 crore. Eris Lifesciences Share Price matters today because the move places the stock at its yearly low even as broader valuation and sector questions remain relevant. Univest figures confirm the price action, but they do not point to a specific company trigger. Eris Lifesciences Share Price today also keeps attention on its fundamental profile, peer positioning and healthcare sector context.

The latest Univest figures show that the stock moved sharply lower after opening at Rs 1,199 and touching a high of Rs 1,222 before slipping to the day’s low of Rs 1,158.95. Eris Lifesciences Share Price now sits at the same level as its 52-week low, which makes the move an event-driven stock news development rather than a routine intraday fluctuation. Investors following Eris Lifesciences Share Price, Eris Lifesciences Stock News and Eris Lifesciences Share Price Today can use the current numbers to read the stock’s valuation, earnings quality and peer comparison without assuming a company-specific trigger.

Eris Lifesciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,158.95
Previous Close	Rs 1,187.65
Today's Move	Rs -28.7 (-2.42%)
Open	Rs 1,199
High	Rs 1,222
Low	Rs 1,158.95
Market Capitalisation	Rs 16,468.27 crore

Eris Lifesciences Ltd. (ERIS) traded at Rs 1,158.95 versus the previous close of Rs 1,187.65, a fall of 2.42%. The stock opened at Rs 1,199, reached a high of Rs 1,222, touched a low of Rs 1,158.95.

Eris Lifesciences Share Price opened above the previous close, traded between Rs 1,199 and Rs 1,222 early in the move, and then eased to Rs 1,158.95. That left the stock down Rs 28.70 on the day, or 2.42%, with the fresh 52-week low matching the current price. For Eris Lifesciences Share Price Today, the key facts are the previous close of Rs 1,187.65, the opening price of Rs 1,199 and the intraday low of Rs 1,158.95. Eris Lifesciences Share Price Live now reflects that yearly low mark within the ongoing session.

For readers scanning Eris Lifesciences Stock News or Eris Lifesciences Share News, the main point is simple: the stock is trading at its one-year low, and the market cap remains Rs 16,468.27 crore. According to latest Univest data, the move is confirmed by price action alone, without a stated event driver. That makes the next section on Eris Lifesciences Fundamental Analysis important for context.

Eris Lifesciences Ltd. (ERIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,468.27 crore
P/E Ratio	25.59x
P/B Ratio	4.09x
ROE	19.23%
ROCE	14.47%
EPS	Rs 46.41
Book Value Per Share	Rs 290.65
Dividend Yield	0%

Eris Lifesciences Ltd. (ERIS) fundamental metrics show P/E 25.59x, P/B 4.09x, ROE 19.23%, ROCE 14.47%. Taken on their own, these numbers offer context rather than a trading signal.

Eris Lifesciences Ltd. has a market capitalisation of Rs 16,468.27 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.59x, P/B at 4.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.23% and ROCE of 14.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.41, book value per share of Rs 290.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.17x, median ROE of 11.69%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.59x
Benchmark Median P/E	32.17x
Benchmark Average P/E	48.59x
Benchmark P/E Range	3.58x to 695.67x
Company P/B Ratio	4.09x
Benchmark Median P/B	2.93x
Company ROE	19.23%
Benchmark Median ROE	11.69%
Company ROCE	14.47%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 16,468.27 crore
Benchmark Median Market Cap	Rs 789.87 crore

Eris Lifesciences Ltd. (ERIS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 25.59x, which is below the benchmark median of 32.17x, a difference of -20.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Eris Lifesciences Ltd. (ERIS) has a ROE of 19.23%, which is above the benchmark median of 11.69%, a difference of +64.5%. Eris Lifesciences Ltd. (ERIS) has a ROCE of 14.47%, which is above the benchmark median of 13.61%, a difference of +6.32%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Alembic Pharmaceuticals Ltd.	APLLTD	16,337.34	23.64	2.8	12.35	11.74
Natco Pharma Ltd.	NATCOPHARM	16,127.95	14.12	1.73	16.3	17.16
Glenmark Life Sciences Ltd.	ALIVUS	16,984.2	28.17	4.87	18.41	24.61
Suven Pharmaceuticals Ltd.	COHANCE	17,092.54	164.61	4.54	4.02	6.12
Jubilant Pharmova Ltd.	JUBLPHARMA	15,617.52	44.7	2.21	5.97	8.69

Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 25.59x compared with the displayed peer median of 28.17x. The comparison is relative and should not be read as a recommendation. Its ROE of 19.23% compares with a peer median of 12.35% across the companies shown in the table. ROCE stood at 14.47% versus the displayed peer median of 11.74%, providing a capital-efficiency comparison. Eris Lifesciences Ltd. (ERIS) has a market capitalisation of Rs 16,468.27 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Eris Lifesciences

• Eris Lifesciences Share Price is at a fresh 52-week low of Rs 1,158.95, which makes the daily move a clear stock news event.
• The stock’s P/E of 25.59 and P/B of 4.09 give Eris Lifesciences Fundamental Analysis immediate relevance.
• ROE of 19.23% and ROCE of 14.47% place Eris Lifesciences Share Price above benchmark medians on profitability.
• Market capitalisation of Rs 16,468.27 crore keeps Eris Lifesciences Share Price in active healthcare sector comparison.
• Peer data shows mixed valuation and return profiles, so Eris Lifesciences Share Price remains important in sector analysis.

About Eris Lifesciences

Eris Lifesciences Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is tracked by investors through Eris Lifesciences Share Price, Eris Lifesciences Stock News and Eris Lifesciences Company News because its business sits in a regulated healthcare market where earnings quality and valuation both matter.

Latest Univest figures show Jun 2026 revenue of Rs 873.25 crore, which adds operating context to Eris Lifesciences Share Price and Eris Lifesciences Financial Results. The company’s listed profile includes strong attention to earnings per share, book value and return ratios, all of which are useful in a stock analysis lens. For readers looking at Eris Lifesciences Stock Performance, the company’s market capitalisation and sector positioning make it a relevant name inside the Indian Stock Market healthcare universe.

Track Eris Lifesciences Share Price on Univest

Use Eris Lifesciences Ltd. (ERIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Univest lets readers track Eris Lifesciences Share Price, Eris Lifesciences Share Price Today, Eris Lifesciences Share Price Live, valuation ratios, 52-week levels and sector context in one place. The same view also helps compare Eris Lifesciences Stock Analysis with healthcare peers and the wider Market News backdrop.

For investors following Eris Lifesciences Latest News, the Univest page brings together the latest price action, market cap, fundamentals and benchmark comparison. That makes Eris Lifesciences Share Price easier to follow during Stock Market Today and Share Market Today moves without relying on commentary alone.

Frequently Asked Questions

Why did Eris Lifesciences Share Price hit a fresh 52-week low?

Ans. Eris Lifesciences Share Price touched Rs 1,158.95, which is also the fresh 52-week low. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock moved -2.42% during the session.

What is Eris Lifesciences Share Price today?

Ans. Eris Lifesciences Share Price is Rs 1,158.95, down 2.42% from the previous close of Rs 1,187.65. The stock opened at Rs 1,199 and later touched Rs 1,158.95. The stock moved -2.42% during the session.

What is the 52-week low for Eris Lifesciences Share Price?

Ans. The fresh 52-week low for Eris Lifesciences Share Price is Rs 1,158.95. The current price is at that same level, so the stock is trading at its one-year low. The stock moved -2.42% during the session.

How large is Eris Lifesciences by market capitalisation?

Ans. Eris Lifesciences Share Price is backed by a market capitalisation of Rs 16,468.27 crore. That places the company well above the industry median in the Univest benchmark set. The company operates in the Healthcare sector.

Is Eris Lifesciences Share Price expensive versus peers?

Ans. Eris Lifesciences Share Price has a P/E of 25.59 and a P/B of 4.09. That is below the industry P/E median but above the industry P/B median in the Univest benchmark.

What do the ROE and ROCE figures show for Eris Lifesciences?

Ans. Eris Lifesciences Share Price comes with ROE of 19.23% and ROCE of 14.47%. Both sit above the industry medians, which gives useful context for Eris Lifesciences Fundamental Analysis. ROE stands at 19.23%.

Does Eris Lifesciences pay a dividend?

Ans. The latest Univest figures show a dividend yield of 0 for Eris Lifesciences Share Price. That means the current yield marker is not contributing to the stock’s listed valuation profile.

How does Eris Lifesciences compare with healthcare peers?

Ans. Eris Lifesciences Share Price sits near peers on market cap, with P/E and ROE between lower-valued and higher-return names in the group. Natco is lower-valued on P/E, while Caplin Point shows stronger ROE.

What should investors monitor next for Eris Lifesciences Share Price?

Ans. Investors can monitor Eris Lifesciences Share Price for whether it stays near the fresh 52-week low, along with future financial results, revenue trends and sector comparison against listed pharmaceuticals peers.